Synthesis of antimicrobial natural products targeting FtsZ: (+)-totarol and related totarane diterpenes

Organic Letters

Volumn 12, Issue 15, 2010, Pages 3324-3327

  Kim, Michelle B ^a   Shaw, Jared T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BIOLOGICAL PRODUCT; CYTOSKELETON PROTEIN; DITERPENE; FTSZ PROTEIN, BACTERIA; TOTARADIOL; TOTAROL; TOTAROLONE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; STEREOISOMERISM; SYNTHESIS; ANTAGONISTS AND INHIBITORS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOLOGICAL PRODUCTS; CYTOSKELETAL PROTEINS; DITERPENES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 77955138547     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol100929z     Document Type: Article

References (69)

1. Vollmer, W. Appl. Microbiol. Biotechnol. 2006, 73, 37-47
2. Lock, R. L.; Harry, E. J. Nat. Rev. Drug. Discov. 2008, 7, 324-338
3. Romberg, L.; Levin, P. A. Annu. Rev. Microbiol. 2003, 57, 125-154
4. Margolin, W. Nat. Rev. Mol. Cell Biol. 2005, 6, 862-871
5. Dajkovic, A.; Lutkenhaus, J. J. Mol. Microbiol. Biotechnol. 2006, 11, 140-151
6. Vollmer, W. Chem. Biol. 2008, 15, 93-94
7. Indirect techniques, including site-directed mutagenesis and mapping of mutations to resistant strains, have provided evidence for the mode of inactivation of one FtsZ inhibitor
8. Haydon, D. J.; Stokes, N. R.; Ure, R.; Galbraith, G.; Bennett, J. M.; Brown, D. R.; Baker, P. J.; Barynin, V. V.; Rice, D. W.; Sedelnikova, S. E.; Heal, J. R.; Sheridan, J. M.; Aiwale, S. T.; Chauhan, P. K.; Srivastava, A.; Taneja, A.; Collins, I.; Errington, J.; Czaplewski, L. G. Science 2008, 321, 1673-1675
9. Wang, J.; Galgoci, A.; Kodali, S.; Herath, K. B.; Jayasuriya, H.; Dorso, K.; Vicente, F.; Gonzalez, A.; Cully, D.; Bramhill, D.; Singh, S. J. Biol. Chem. 2003, 278, 44424-44428
10. Urgaonkar, S.; La Pierre, H. S.; Meir, I.; Lund, H.; RayChaudhuri, D.; Shaw, J. T. Org. Lett. 2005, 7, 5609-5612
11. Domadia, P. N.; Bhunia, A.; Sivaraman, J.; Swarup, S.; Dasgupta, D. Biochemistry 2008, 47, 3225-3234
12. Kanoh, K.; Adachi, K.; Matsuda, S.; Shizuri, Y.; Yasumoto, K.; Kusumi, T.; Okumura, K.; Kirikae, T. J. Antibiot. 2008, 61, 192-194
13. Curcumin has been reported to target many proteins, including both FtsZ and tubulin
14. Rai, D.; Singh, J. K.; Roy, N.; Panda, D. Biochem. J. 2008, 410, 147-155
15. Gupta, K. K.; Bharne, S. S.; Rathinasamy, K.; Naik, N. R.; Panda, D. FEBS J. 2006, 273, 5320-5332
16. Much of the history of totarol has been reviewed, see
17. Bendall, J. G.; Cambie, R. C. Aust. J. Chem. 1995, 48, 883-917
18. Nixon, D.; Hobbs, D. NZ Family Phys. 2006, 33, 253-255, http://www.cosmeticsdesign.com/Formulation-Science/Totarol-goes-global (accessed on Aug 16, 2009
19. Muroi, H.; Kubo, I. Biosci., Biotechnol., Biochem. 1994, 58, 1925-1926
20. Muroi, H.; Kubo, I. J. Appl. Bacteriol. 1996, 80, 387-394
21. Kubo, I.; Muroi, H.; Himejima, M. J. Nat. Prod. 1992, 55, 1436-1440
22. Haraguchi, H.; Oike, S.; Muroi, H.; Kubo, I. Planta Med. 1996, 62, 122-125
23. Constantine, G. H.; Karchesy, J. J.; Franzblau, S. G.; LaFleur, L. E. Fitoterapia 2001, 72, 572-574
24. Jaiswal, R.; Beuria, T. K.; Mohan, R.; Mahajan, S. K.; Panda, D. Biochemistry 2007, 46, 4211-4220
25. Barltrop, J. A.; Rogers, N. A. J. J. Chem. Soc. 1958, 2566-2572
26. Tada, M.; Kurabe, J.; Yasue, H.; Ikuta, T. Chem. Pharm. Bull. 2008, 56, 287-291 Additional synthetic work is described in ref 6.
27. Matsumoto, T.; Suetsugu, A. Bull. Chem. Soc. Jpn. 1979, 52, 1450-1453
28. Marcos, I. S.; Cubillo, M. A.; Moro, R. F.; Diez, D.; Basabe, P.; Sanz, F.; Urones, J. G. Tetrahedron Lett. 2003, 44, 8831-8835
29. Marcos, I. S.; Cubillo, M. A.; Moro, R. F.; Carballares, S.; Diez, D.; Basabe, P.; Llamazares, C. F.; Beneitez, A.; Sanz, F.; Broughton, H. B.; Urones, J. G. Tetrahedron 2005, 61, 977-1003
30. Ishihara, K.; Ishibashi, H.; Yamamoto, H. J. Am. Chem. Soc. 2001, 123, 1505-1506
31. Ishibashi, H.; Ishihara, K.; Yamamoto, H. J. Am. Chem. Soc. 2004, 126, 11122-11123
32. Youn, S. W.; Pastine, S. J.; Sames, D. Org. Lett. 2004, 6, 581-584
33. Sakakura, A.; Ukai, A.; Ishihara, K. Nature 2007, 445, 900-903
34. Evans, G. B.; Furneaux, R. H. Bioorg. Med. Chem. 2000, 8, 1653-1662
35. Evans, G. B.; Furneaux, R. H.; Gainsford, G. J.; Murphy, M. P. Bioorg. Med. Chem. 2000, 8, 1663-1675
36. Evans, G. B.; Furneaux, R. H.; Gravestock, M. B.; Lynch, G. P.; Scott, G. K. Bioorg. Med. Chem. 1999, 7, 1953-1964
37. Zhao, J.-F.; Zhao, Y.-J.; Loh, T.-P. Chem. Commun. 2008, 1353-1355
38. Baeckvall, J. E.; Sellen, M. Chem. Commun. 1987, 827-829
39. Baeckvall, J. E.; Sellen, M.; Grant, B. J. Am. Chem. Soc. 1990, 112, 6615-6621
40. Gansaeuer, A.; Justicia, J.; Rosales, A.; Rinker, B. Synlett 2005, 1954-1956
41. Rosales, V.; Zambrano, J. L.; Demuth, M. J. Org. Chem. 2002, 67, 1167-1170
42. Araki, S.; Sato, T.; Butsugan, Y. Chem. Commun. 1982, 285-286
43. Crispino, G. A.; Sharpless, K. B. Tetrahedron Lett. 1992, 33, 4273-4274
44. Corey, E. J.; Noe, M. C.; Lin, S. Tetrahedron Lett. 1995, 36, 8741-8744
45. Corey, E. J.; Zhang, J. Org. Lett. 2001, 3, 3211-3214
46. Hoshino, T.; Yonemura, Y.; Abe, T.; Sugino, Y. Org. Biomol. Chem. 2007, 5, 792-801
47. A high level of steric control has been observed in a substrate related to 4 that is shorter by one carbon between the phenyl ring and the central alkene, see
48. Neighbors, J. D.; Mente, N. R.; Boss, K. D.; Zehnder, D. W.; Wiemer, D. F. Tetrahedron Lett. 2008, 49, 516-519
49. Sakaguchi, J.; Higashi, T.; Azuma, T.; Suzuki, T.; Iwasaki, N.; Kondo, N.; Nagata, O.; Kato, H.; Hanaoka, M. Chem. Pharm. Bull. 2001, 49, 788-790
50. Ogasawara, M.; Yoshida, K.; Kamei, H.; Kato, K.; Uozumi, Y.; Hayashi, T. Tetrahedron: Asymmetry 1998, 9, 1779-1787
51. Meyers, A. I.; Willemsen, J. J. Tetrahedron 1998, 54, 10493-10511
52. Meyers, A. I.; Gabel, R.; Mihelich, E. D. J. Org. Chem. 1978, 43, 1372-1379
53. Fukuda, Y.; Seto, S.; Furuta, H.; Ebisu, H.; Oomori, Y.; Terashima, S. J. Med. Chem. 2001, 44, 1396-1406
54. Kaplan, L. J.; Weisman, G. R.; Cram, D. J. J. Org. Chem. 1979, 44, 2226-2233 These conditions were optimized for execution in a microwave reactor. See the Supporting Information.
55. Use of the Grignard reagent was reported by Nishizawa and co-workers. Although the preparation does not appear in the experimental section of this publication, the procedure was provided to us by Prof. Nishizawa, see
56. Imagawa, H.; Iyenaga, T.; Nishizawa, M. Synlett 2005, 703-705
57. In one run, 18 was isolated as an mixture with bromide 16a and 17 (from protonation of 6a) in 43% yield.
58. Richtzenhain, H.; Nippus, P. Chem. Ber. 1949, 82, 408-417
59. Albert, J. S.; Ohnmacht, C.; Bernstein, P. R.; Rumsey, W. L.; Aharony, D.; Alelyunas, Y.; Russell, D. J.; Potts, W.; Sherwood, S. A.; Shen, L.; Dedinas, R. F.; Palmer, W. E.; Russell, K. J. Med. Chem. 2004, 47, 519-529
60. Parker, J. S.; Smith, N. A.; Welham, M. J.; Moss, W. O. Org. Process Res. Dev. 2004, 8, 45-50
61. Meyers, A. I.; Mihelich, E. D. J. Am. Chem. Soc. 1975, 97, 7383-7385
62. Enantiomeric excess was determined by chiral HPLC after cyclization to 24 (Scheme 3). See the Supporting Information for details.
63. Gutierrez, C. G.; Stringham, R. A.; Nitasaka, T.; Glasscock, K. G. J. Org. Chem. 1980, 45, 3393-3395
64. Use of Raney nickel resulted in competitive alkene reduction, as observed by Bruggemann, see: Bruggemann, M.; Holst, C.; Hoppe, D. Eur. J. Org. Chem. 2001, 647-654
65. Node, M.; Nishide, K.; Fuji, K.; Fujita, E. J. Org. Chem. 1980, 45, 4275-4277
66. Edsall, A. B.; Mohanakrishnan, A. K.; Yang, D.; Fanwick, P. E.; Hamel, E.; Hanson, A. D.; Agoston, G. E.; Cushman, M. J. Med. Chem. 2004, 47, 5126-5139
67. Martin, R.; Entchev, E. V.; Dabritz, F.; Kurzchalia, T. V.; Knolker, H. J. Eur. J. Org. Chem. 2009, 3703-3714
68. Imanishi, T.; Yamashita, M.; Matsui, M.; Tanaka, T.; Iwata, C. Chem. Pharm. Bull. 1989, 37, 3114-3116
69. Huang, M. J. Am. Chem. Soc. 1949, 71, 3301-3303